Aug 23, 2019
HotSpot Therapeutics Announces Acquisition of Macroceutics, Inc.
Oct 26, 2018
Court Issues Ruling in ZYTIGA® Patent Infringement Litigation
Jul 17, 2018
HotSpot Therapeutics Completes $45 Million Series A Financing to Advance New Approach to Allosteric Drug Discovery
Apr 10, 2018
AbbVie and Neurocrine Biosciences Announce PDUFA Target Date of Q3 2018 for Elagolix in Endometriosis-Associated Pain
Mar 05, 2018
Julianne Hough Encourages Women to "Speak Up for Endo" during Endometriosis Awareness Month
Feb 26, 2018
Trovagene Announces Fourth Quarter and Full-Year 2017 Results
Feb 08, 2018
ZYTIGA® (abiraterone acetate) Plus Prednisone Approved for Treatment of Earlier Form of Metastatic Prostate Cancer
Jan 18, 2018
Amerigen's petition leads to U.S. Zytiga® patent invalidation
Jan 17, 2018
Johnson & Johnson Issues Statement on ZYTIGA® Inter Partes Reviews
Nov 09, 2017
Trovagene Announces Third Quarter 2017 Company Highlights and Financial Results
Oct 30, 2017
CMP Pharma, Inc Announces That CaroSpir®, The First And Only FDA-Approved Spironolactone Oral Suspension, Is Now Available
Sep 14, 2017
Janssen Submits Supplemental New Drug Application to U.S. FDA for ZYTIGA® (abiraterone acetate) to Treat Men with Earlier Stages of Metastatic Prostate Cancer
Aug 09, 2017
Global Isoflavones Market Analysis & Forecast 2017-2021 - Rise in the Demand of Nutraceuticals Supplements for Disease Prevention
Aug 07, 2017
CMP Pharma, Inc. Announces FDA Approval of CaroSpir® (Spironolactone Oral Suspension, 25 mg/5 mL)